Skip to content

Clinical trials

Phase 3 Major Depressive Disorder trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 3 Country / region: Canada Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20042
20054
20062
20072
20081
20094
20103
20119
20123
20132
20145
20153
20164
20171
20183
20191
20201
20222
20232
20241
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Terminated7
Recruiting6
Unknown status2
Withdrawn1
Not yet recruiting1
Suspended1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto7
Eli Lilly and Company5
Janssen Research & Development, LLC5
Otsuka Pharmaceutical Development & Commercialization, Inc.5
Alkermes, Inc.4
Forest Laboratories4
H. Lundbeck A/S4
AstraZeneca3
Neurocrine Biosciences3
Neumora Therapeutics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder65
Depressive Disorder6
Mood Disorders6
Bipolar Disorder5
Mental Disorders4
Depressive Disorder, Treatment-Resistant2
Anhedonia1
Cognitive Dysfunction1
Depression, Postpartum1
Memory Disorders1

Trials

Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.